Clinical Trial

Quantitative Refractive Crosslinking in Presbyopia Aged Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
An 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-21.
Trial Details
NCT Number NCT07137767
Lead Sponsor TECLens, Inc.
Collaborators: Renato Ambrósio, MD - Rio Vision; Tijuca Rio de Janeiro, Brazil, Juan Batlle, Jr. MD - Laser Center; Santo Domingo, Dominican Rep.
Conditions Presbyopia
Enrollment 25 participants
Start Date 2025-08-31
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-29